{"id":"W1984877106","doi":"10.1016/j.ygyno.2007.02.018","title":"UCN-01 in combination with topotecan in patients with advanced recurrent ovarian cancer: A study of the Princess Margaret Hospital Phase II consortium","year":2007,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":false,"ca_institutions":"Cancer Care Ontario; Juravinski Cancer Centre; Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Topotecan; Medicine; Neutropenia; Ovarian cancer; Internal medicine; Oncology; Phases of clinical research; Chemotherapy; Carboplatin; Progressive disease; Cancer; Febrile neutropenia; Surgery; Cisplatin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030937,0.0008561829,0.002551025,0.0005475176,0.0004973097,0.001258498,0.0009693963,0.000978425,0.001745686],"category_scores_gemma":[0.002500576,0.0005760921,0.001383156,0.0009015963,0.001072272,0.001136209,0.000498921,0.002331942,0.0003180093],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001526912,"about_ca_system_score_gemma":0.001880648,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002838262,"about_ca_topic_score_gemma":0.005991074,"domain_scores_codex":[0.9984408,0.0009883695,0.00006015831,0.0001805492,0.0001615663,0.0001686425],"domain_scores_gemma":[0.9982247,0.0004897564,0.0003163065,0.0002031618,0.00009644557,0.0006697363],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7155707,0.04360415,0.06576914,0.000500497,0.003789094,0.0003308487,0.000571349,0.003128662,0.01319902,0.0002841845,0.003035004,0.1502174],"study_design_scores_gemma":[0.3451543,0.5014092,0.1423497,0.00006217089,0.002068159,0.0007444526,0.0002813573,0.002009724,0.002414107,0.0001641372,0.003277643,0.00006514124],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9976701,0.001123078,0.00006145352,0.0001753942,0.00002846718,0.0001719714,0.0002199179,0.000009502213,0.0005400867],"genre_scores_gemma":[0.9957694,0.001283646,0.0003805219,0.0003569845,0.00009621862,0.000233225,0.001018255,0.0000140888,0.0008475099],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0030937,"threshold_uncertainty_score":0.0163613,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01083257477411506,"score_gpt":0.305409538293352,"score_spread":0.294576963519237,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}